PREreview of Advancements in Cancer Immunotherapy: Exploring Treatment Options

This study places cancer immunotherapy (CI) in a broader scientific and historical context, providing a thoughtful reflection on its evolution and future. This preprint chronicles the evolution of tumor immunosurveillance and significant breakthroughs in CI, such as monoclonal antibodies, immune checkpoint inhibitors, and cancer vaccines, and elaborately discusses the progress and prospects of emerging immune cell therapies. It addresses key challenges for CI, such as immune evasion, autoimmune toxicities, and tumor heterogeneity, and projects future trajectories emphasizing personalized and combination therapies. Overall, this work provides an informative overview of the trajectory and potential of cancer immunotherapy, with a robust emphasis on the scientific mechanisms and future innovations. This review is likely to advance academic knowledge and scholarly conversation by presenting a comprehensive and up-to-date synthesis of developments in IC, framing it as a significant medical pillar with profound implications for precision medicine. It has the potential to reach an interdisciplinary audience by bridging the gap between cancer biology and the clinical, ethical, and economic domains. A structured analysis of clinical trial data, survival outcomes, and quantitative metrics of efficacy for the therapeutic interventions discussed would further strengthen the paper’s scientific rigor and provide a more balanced evaluation of current CI approaches. Furthermore, this review touches upon the scalability and accessibility issues surrounding CI therapies, which are crucial given the high cost and complexity involved. A more extensive discussion of the economic and logistical challenges and potential solutions would enhance the practical relevance of the manuscript, particularly regarding the global applicability of these treatments.

Competing interests

The author declares that they have no competing interests.

Use of Artificial Intelligence (AI)

The author declares that they used generative AI to come up with new ideas for their review.